These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 34976290)

  • 1. Safety and Efficacy of VP-102 (Cantharidin, 0.7% w/v) in Molluscum Contagiosum by Body Region:
    Eichenfield LF; Kwong P; Gonzalez ME; Yan A; D'Arnaud P; Burnett P; Olivadoti M
    J Clin Aesthet Dermatol; 2021 Oct; 14(10):42-47. PubMed ID: 34976290
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pooled Results of Two Randomized Phase III Trials Evaluating VP-102, a Drug-Device Combination Product Containing Cantharidin 0.7% (w/v) for the Treatment of Molluscum Contagiosum.
    Eichenfield LF; Siegfried E; Kwong P; McBride M; Rieger J; Glover D; Willson C; Davidson M; Burnett P; Olivadoti M
    Am J Clin Dermatol; 2021 Mar; 22(2):257-265. PubMed ID: 33599960
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Safety and Efficacy of VP-102, a Proprietary, Drug-Device Combination Product Containing Cantharidin, 0.7% (w/v), in Children and Adults With Molluscum Contagiosum: Two Phase 3 Randomized Clinical Trials.
    Eichenfield LF; McFalda W; Brabec B; Siegfried E; Kwong P; McBride M; Rieger J; Willson C; Davidson M; Burnett P
    JAMA Dermatol; 2020 Dec; 156(12):1315-1323. PubMed ID: 32965495
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A Phase 2 Open-Label Study to Evaluate VP-102 for the Treatment of Molluscum Contagiosum.
    Niazi S; Brabec B; Anschutz L; Willson C; Davidson M; Burnett P
    J Drugs Dermatol; 2021 Jan; 20(1):70-75. PubMed ID: 33400412
    [TBL] [Abstract][Full Text] [Related]  

  • 5. YCANTH
    Gupta AK; Mann A; Vincent K; Abramovits W
    Skinmed; 2023; 21(5):360-363. PubMed ID: 37945366
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy and Safety of Topical Cantharidin Treatment for Molluscum Contagiosum and Warts: A Systematic Review.
    Vakharia PP; Chopra R; Silverberg NB; Silverberg JI
    Am J Clin Dermatol; 2018 Dec; 19(6):791-803. PubMed ID: 30097988
    [TBL] [Abstract][Full Text] [Related]  

  • 7. COVE-1: A Phase 2, Open-Label Study to Evaluate Efficacy and Safety and the Optimal Regimen of VP-102, a Proprietary Drug-Device Product Containing Topical Cantharidin (0.7% w/v) Under Occlusion for the Treatment of Common Warts.
    Guenthner S; McFalda W; Kwong P; Eads K; McCafferty M; Rieger J; Glover DK; Willson C; Burnett P; Olivadoti M
    Dermatol Ther (Heidelb); 2021 Oct; 11(5):1623-1634. PubMed ID: 34286459
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Safety and efficacy of topical cantharidin for the treatment of pediatric molluscum contagiosum: a prospective, randomized, double-blind, placebo-controlled pilot trial.
    Guzman AK; Schairer DO; Garelik JL; Cohen SR
    Int J Dermatol; 2018 Aug; 57(8):1001-1006. PubMed ID: 29904968
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Phase II, Double-Blind, Vehicle-Controlled Study to Determine the Cantharidin Dose Regimen, Efficacy, Safety, and Tolerability of VP-102 in Subjects with External Genital Warts.
    Guenthner S; McFalda W; Tate M; Eads K; Rieger J; Glover DK; Willson C; Rumney P; Rosen T; Andres J; Olivadoti M
    Am J Clin Dermatol; 2021 Nov; 22(6):867-875. PubMed ID: 34515985
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy and Safety of Topical Nitric Oxide-Releasing Berdazimer Gel in Patients With Molluscum Contagiosum: A Phase 3 Randomized Clinical Trial.
    Browning JC; Enloe C; Cartwright M; Hebert A; Paller AS; Hebert D; Kowalewski EK; Maeda-Chubachi T
    JAMA Dermatol; 2022 Aug; 158(8):871-878. PubMed ID: 35830173
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Topical Cantharidin in the Management of Molluscum Contagiosum: Preliminary Assessment of an Ether-free, Pharmaceutical-grade Formulation.
    Del Rosso JQ; Kircik L
    J Clin Aesthet Dermatol; 2019 Feb; 12(2):27-30. PubMed ID: 30881580
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A Patient-Centered Perspective of Molluscum Contagiosum as Reported by B-SIMPLE4 Clinical Trial Patients and Caregivers: Global Impression of Change and Exit Interview Substudy Results.
    Browning JC; Cartwright M; Thorla I; Martin SA; Olayinka-Amao O; Maeda-Chubachi T
    Am J Clin Dermatol; 2023 Jan; 24(1):119-133. PubMed ID: 36287306
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Berdazimer gel for molluscum contagiosum: An integrated analysis of 3 randomized controlled trials.
    Sugarman JL; Hebert A; Browning JC; Paller AS; Stripling S; Green LJ; Cartwright M; Enloe C; Wells N; Maeda-Chubachi T
    J Am Acad Dermatol; 2024 Feb; 90(2):299-308. PubMed ID: 37804936
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy and safety of topical application of 15% and 10% potassium hydroxide for the treatment of Molluscum contagiosum.
    Teixidó C; Díez O; Marsal JR; Giner-Soriano M; Pera H; Martinez M; Galindo-Ortego G; Schoenenberger JA; Real J; Cruz I; Morros R
    Pediatr Dermatol; 2018 May; 35(3):336-342. PubMed ID: 29479727
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Berdazimer gel for molluscum contagiosum in patients with atopic dermatitis.
    Paller AS; Green LJ; Silverberg N; Stripling S; Cartwright M; Enloe C; Wells N; Kowalewski EK; Maeda-Chubachi T
    Pediatr Dermatol; 2024; 41(3):438-444. PubMed ID: 38413239
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molluscum Contagiosum: An Update.
    Leung AKC; Barankin B; Hon KLE
    Recent Pat Inflamm Allergy Drug Discov; 2017; 11(1):22-31. PubMed ID: 28521677
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interventions for cutaneous molluscum contagiosum.
    van der Wouden JC; van der Sande R; Kruithof EJ; Sollie A; van Suijlekom-Smit LW; Koning S
    Cochrane Database Syst Rev; 2017 May; 5(5):CD004767. PubMed ID: 28513067
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison Of Efficacy Of 10% Potassium Hydroxide Solution Versus Cryotherapy In Treatment Of Molluscum Contagiosum.
    Qureshi A; Zeb M; Jalal-Ud-Din M; Sheikh ZI; Alam MA; Anwar SA
    J Ayub Med Coll Abbottabad; 2016; 28(2):382-385. PubMed ID: 28718569
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cantharidin for the treatment of molluscum contagiosum: a prospective, double-blinded, placebo-controlled trial.
    Coloe Dosal J; Stewart PW; Lin JA; Williams CS; Morrell DS
    Pediatr Dermatol; 2014; 31(4):440-9. PubMed ID: 22897595
    [TBL] [Abstract][Full Text] [Related]  

  • 20. New Developing Treatments for Molluscum Contagiosum.
    Lacarrubba F; Micali G; Trecarichi AC; Quattrocchi E; Monfrecola G; Verzì AE
    Dermatol Ther (Heidelb); 2022 Dec; 12(12):2669-2678. PubMed ID: 36239905
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.